| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R D Jackson, W B Malarke. Sequential prolactin evaluation of a "cured" patient with recurrence of prolactinoma. The American journal of medicine. vol 82. issue 2. 1987-03-17. PMID:3812533. |
one year postoperatively, the hyperprolactinemia recurred, prolactin release was markedly resistant to dopamine, and an abnormal 24-hour prolactin profile of release was present. |
1987-03-17 |
2023-08-11 |
human |
| R D Jackson, W B Malarke. Sequential prolactin evaluation of a "cured" patient with recurrence of prolactinoma. The American journal of medicine. vol 82. issue 2. 1987-03-17. PMID:3812533. |
additionally, an abnormal prolactin response to dopamine was noted to precede the development of hyperprolactinemia with tumor recurrence. |
1987-03-17 |
2023-08-11 |
human |
| G M Mesfin, G A Johnson, M J Higgins, D F Morri. Mechanism of anestrus in rats treated with an antihypertensive agent, losulazine hydrochloride. Toxicology and applied pharmacology. vol 87. issue 1. 1987-02-10. PMID:3099429. |
these results suggest that hyperprolactinemia mediated through hypothalamic dopamine depletion is the mechanism of anestrus in rats treated with losulazine. |
1987-02-10 |
2023-08-11 |
rat |
| J H Mattox, M T Buckman, J Bernstein, D Pathak, R Kellne. Dopamine agonists for reducing depression associated with hyperprolactinemia. The Journal of reproductive medicine. vol 31. issue 8. 1986-12-03. PMID:3772890. |
dopamine agonists for reducing depression associated with hyperprolactinemia. |
1986-12-03 |
2023-08-11 |
Not clear |
| E G Veĭnberg, F G Vetrogon, M A Sabakhtarashvili, I Kh Marganii. [Serotonin, histamine and catecholamine levels in patients with the hyperprolactinemia syndrome]. Problemy endokrinologii. vol 32. issue 4. 1986-11-10. PMID:3763571. |
a total of 76 patients aged 18-39 with hyperprolactinemia were studied for the blood levels of serotonin and histamine and for the urinary ones of epinephrine, norepinephrine, dopa and dopamine. |
1986-11-10 |
2023-08-11 |
Not clear |
| J Arita, F Kimur. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia. Endocrinology. vol 119. issue 4. 1986-10-30. PMID:3019639. |
characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia. |
1986-10-30 |
2023-08-11 |
rat |
| A D Solov'eva, E G Filatova, M S Dobrotin. [Status of nonspecific brain systems in various hypothalamic syndromes]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). vol 86. issue 6. 1986-10-01. PMID:3751422. |
examination of 41 women with the hypothalamic syndrome showed that they had ergotrophic insufficiency expressed both in the specific hypothalamus-pituitary system (hyperprolactinemia) and in nonspecific systems (deficiency of the activation systems of the brain sympathetic activity at the periphery and the emotional syndrome), which suggests the deficit of dopamine not only in the tuberoinfundibular but also in mesolimbic systems. |
1986-10-01 |
2023-08-11 |
Not clear |
| K Y Ho, G A Smythe, L Lazaru. Normal lactotroph sensitivity to graded low-dose dopamine infusions in pathological hyperprolactinemia. Neuroendocrinology. vol 43. issue 2. 1986-07-25. PMID:3724984. |
normal lactotroph sensitivity to graded low-dose dopamine infusions in pathological hyperprolactinemia. |
1986-07-25 |
2023-08-11 |
human |
| K Y Ho, G A Smythe, L Lazaru. Normal lactotroph sensitivity to graded low-dose dopamine infusions in pathological hyperprolactinemia. Neuroendocrinology. vol 43. issue 2. 1986-07-25. PMID:3724984. |
the question as to whether there is lactotroph resistance to dopamine (da) in pathological hyperprolactinemia (php) is unresolved. |
1986-07-25 |
2023-08-11 |
human |
| J Torres-Noriega, L A Frohma. Hyperprolactinemia associated with chronic renal failure in the rat. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 18. issue 4. 1986-06-27. PMID:3710420. |
patients with crf exhibit hyperprolactinemia and resistance to the prolactin-suppressive effects of dopamine. |
1986-06-27 |
2023-08-11 |
human |
| A Vidaller, L Llorente, F Larrea, J P Mendez, J Alcocer-Varela, D Alarcon-Segovi. T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment. Clinical immunology and immunopathology. vol 38. issue 3. 1986-03-24. PMID:2935343. |
we studied four patients with tumoral hyperprolactinemia and normal ovarian function before and after prolactine levels had become normal with treatment with bromocriptine (brc), a dopamine agonist that inhibits prolactin release. |
1986-03-24 |
2023-08-11 |
Not clear |
| O A Kletzky, R Borenstein, G N Mileikowsk. Pergolide and bromocriptine for the treatment of patients with hyperprolactinemia. American journal of obstetrics and gynecology. vol 154. issue 2. 1986-03-21. PMID:3080892. |
it can be concluded that either dopamine agonist can be safely given to patients with hyperprolactinemia. |
1986-03-21 |
2023-08-11 |
Not clear |
| E del Poz. Management of borderline hyperprolactinemia. Hormone research. vol 22. issue 3. 1985-12-10. PMID:4054840. |
the concept of "transient hyperprolactinemia' is analyzed and alternative explanations for the positive results of dopamine agonist therapy in this particular condition are proposed. |
1985-12-10 |
2023-08-11 |
Not clear |
| J H Matto. Dopamine agonists in hyperprolactinemia. Fertility and sterility. vol 44. issue 4. 1985-11-25. PMID:4054333. |
dopamine agonists in hyperprolactinemia. |
1985-11-25 |
2023-08-11 |
Not clear |
| K Sekiya, T Karashima, S Ikuyama, K Muta, K Kato, H Ibayash. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia. Endocrinologia japonica. vol 32. issue 2. 1985-10-31. PMID:4042986. |
in order to clarify the dopaminergic regulation of prl secretion in patients with acromegaly and hyperprolactinemia, the effects of nomifensine, a central dopamine agonist, fk 33-824, a centrally antidopaminergically acting agent, and domperidone, a peripheral dopamine antagonist, on plasma prl in these patients were studied. |
1985-10-31 |
2023-08-11 |
human |
| K Sekiya, T Karashima, S Ikuyama, K Muta, K Kato, H Ibayash. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia. Endocrinologia japonica. vol 32. issue 2. 1985-10-31. PMID:4042986. |
these results suggest that in acromegalic patients there may be a disturbance in dopamine related neurotransmission and that such disorders also seem to be present in patients with hyperprolactinemia, with or without a pituitary tumor. |
1985-10-31 |
2023-08-11 |
human |
| J R Peters, M D Rodriguez-Arnao, S M Foord, C Edwards, C Dieguez, S Woodhead, R Hall, M F Scanlo. Differential effects of acute DA receptor blockade with domperidone on LH and TSH release in patients with hyperprolactinemia. Journal of endocrinological investigation. vol 8. issue 2. 1985-10-07. PMID:4031383. |
since dopamine (da) has been implicated in the inhibitory control of both tsh and lh, we have compared tsh and lh levels following dopamine (da) receptor blockade with domperidone in patients with hyperprolactinemia due to presumed prolactinomas. |
1985-10-07 |
2023-08-11 |
human |
| W W Morgan, A Bartke, D C Herber. The effect of long-term diethylstilbestrol treatment or hyperprolactinemia on the response of the tuberoinfundibular dopamine neurons to elevated prolactin. Brain research. vol 335. issue 2. 1985-08-15. PMID:3924343. |
the effect of long-term diethylstilbestrol treatment or hyperprolactinemia on the response of the tuberoinfundibular dopamine neurons to elevated prolactin. |
1985-08-15 |
2023-08-11 |
rat |
| E Ghigo, E Ciccarelli, A Novelli, M Massobrio, E E Müller, F Camann. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia. Journal of endocrinological investigation. vol 8. issue 1. 1985-06-03. PMID:3989236. |
prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia. |
1985-06-03 |
2023-08-11 |
human |
| E Ghigo, E Ciccarelli, A Novelli, M Massobrio, E E Müller, F Camann. Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia. Journal of endocrinological investigation. vol 8. issue 1. 1985-06-03. PMID:3989236. |
to better understand the state of dopamine (da) neurotransmission in the tuberoinfundibular da system (tida), monoiodotyrosine (3-iodo-l-tyrosine, mit), a potent inhibitor of da synthesis, was acutely administered to 8 normal women, 7 postpartum women, 8 women with pathological hyperprolactinemia and 5 women after successful removal of a prolactinoma. |
1985-06-03 |
2023-08-11 |
human |